AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Boston Scientific

Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

AHCO or BSX: Which Is the Better Value Stock Right Now?

Applied Materials

Lam Research

NVIDIA

Powell Industries

Ultra Clean

They may not be household names like Meta Platforms Inc. NASDAQ: META or investor favorites like Nvidia Corp. NASDAQ: NVDA, but several small stocks, such as Ultra Clean Holdings, Inc. NASDAQ: UCTT, Powell Industries Inc. NASDAQ: POWL and AdaptHealth Corp. NASDAQ: AHCO are outperforming major indexes.

3 Small-Cap Leaders Poised for Significant Growth

Abercrombie & Fitch

DXP Enterprises

Kaman Corporation

Shake Shack

Tired of the giant Magnificent Seven S&P 500 stocks, yet? Some investors are scrambling to pick up some small-cap stocks left between the cracks.

Investors Rush To Buy 7 Small Stocks Before Everyone Else Does

Haleon PLC

Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?

AHCO vs. HLN: Which Stock Should Value Investors Buy Now?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Jason Clemens, CFO, will participate in the Barclays 26th Annual Global Healthcare Conference, being held in Miami, on Tuesday, March 12, 2024, including a fireside chat at.

AdaptHealth Corp. to Participate in the Barclays 26th Annual Global Healthcare Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Jason Clemens, CFO, will participate in the 3rd Annual Jefferies Value Based Care Summit, being held in Miami, on Monday, March 11, 2024, including a fireside chat at 4:15p.

AdaptHealth Corp. to Participate in the 3rd Annual Jefferies Value Based Care Summit

AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript

AdaptHealth badly missed analysts' consensus earnings estimate for the fourth quarter, but beat their revenue estimate. The earnings miss was due entirely to a goodwill write-down.

Why AdaptHealth Stock Is Skyrocketing Today

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2023. Full Year 2023 Results and Highlights All comparisons are to the year ended December 31, 2022 unless otherwise stated. Net revenue was $3,200.

AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2023 financial results before the opening of the financial markets on Tuesday, February 27, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activi.

AdaptHealth Corp. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

NEW YORK--(BUSINESS WIRE)-- #AHCO--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) on behalf of long-term stockholders following a class action complaint that was filed against AdaptHealth on October 24, 2023 with a Class Period from August 4, 2020 to February 27, 2023; and/or (ii) traceable to the Company's secondary public offering conducted on or around January 5, 2021 (the “SPO”). Our in.

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating AdaptHealth Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses In Excess of $100,000 to Contact the Firm

NEW YORK, Dec. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the "Class Period") and/or (2) AdaptHealth common stock pursuant and/or traceable to the Company's secondary public offering (the "SPO") conducted on or around January 5, 2021, of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

AHCO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important December 26 Deadline in Securities Class Action - AHCO

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 26, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) common stock: (1) between August 4, 2020 and February 27, 2023, inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to the Company's January 2021 secondary public offering (the “SPO”). If you are a.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AdaptHealth Corp. (AHCO)

LOS ANGELES, CA / ACCESSWIRE / December 21, 2023 /The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses of $100,000 to Contact the Firm

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Wednesday, January 10, 2024, including a presentation at 5:15pm PT. The webcast link and related presentation m.

AdaptHealth Corp. to Participate in Upcoming Investor Conference

NEW YORK , Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AdaptHealth Corp. - AHCO

LOS ANGELES , Dec. 18, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO).

AHCO Investors Have Opportunity to Lead AdaptHealth Corp. Securities Fraud Lawsuit

NEW ORLEANS , Dec. 15, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 26, 2023 to file lead plaintiff applications in a securities class action lawsuit against AdaptHealth Corp. (NasdaqCM: AHCO), if they purchased or otherwise acquired the Company's shares (i) between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"); and/or (ii) pursuant and/or traceable to the Company's January 2021 secondary public offering (the "SPO"). This action is pending in the United States District Court for the Eastern District of Pennsylvania.

ADAPTHEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AdaptHealth Corp. - AHCO

LOS ANGELES, CA / ACCESSWIRE / December 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses In Excess of $100,000 to Contact the Firm

CEDARHURST, N.Y. , Dec. 13, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of AdaptHealth Corp. (NasdaqCM: AHCO), if they purchased or otherwise acquired the Company's shares (i) between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"); and/or (ii) pursuant and/or traceable to the Company's January 2021 secondary public offering (the "SPO").

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of AdaptHealth Corp. - AHCO

LOS ANGELES, CA / ACCESSWIRE / December 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses to Contact the Firm

NEW YORK , Dec. 11, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the "Class Period") and/or (2) AdaptHealth common stock pursuant and/or traceable to the Company's secondary public offering (the "SPO") conducted on or around January 5, 2021, of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

News for AdaptHealth Corp Stock (AHCO)